External validation of an algorithm combining multi‐analyte blood tests (FibroTest‐LCR1‐LCR2) to identify subjects at risk of hepatocellular carcinoma in patients with chronic liver disease - Université Paris Cité Accéder directement au contenu
Article Dans Une Revue GastroHep Année : 2019

External validation of an algorithm combining multi‐analyte blood tests (FibroTest‐LCR1‐LCR2) to identify subjects at risk of hepatocellular carcinoma in patients with chronic liver disease

Dates et versions

hal-03975253 , version 1 (06-02-2023)

Identifiants

Citer

Valentina Peta, Marianne Ziol, Françoise Imbert-Bismut, Angela Sutton, Denis Monneret, et al.. External validation of an algorithm combining multi‐analyte blood tests (FibroTest‐LCR1‐LCR2) to identify subjects at risk of hepatocellular carcinoma in patients with chronic liver disease. GastroHep, 2019, 1 (3), pp.146-153. ⟨10.1002/ygh2.339⟩. ⟨hal-03975253⟩
17 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More